E Fund Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$542K	Buy	+23,007	New	+$587K	0.02%	278
2025 Q2	$241K	Buy	17,184 +2,197	+15%	+$30.8K	0.01%	340
2025 Q1	$234K	Buy	14,987 +108	+0.7%	+$1.52K	0.01%	347
2024 Q4	$207K	Sell	14,879 -2,906	-16%	-$31.8K	0.01%	358
2024 Q3	$165K	Buy	17,785 +2,026	+13%	+$20K	0.01%	337
2024 Q2	$147K	Sell	15,759 -23,107	-59%	-$209K	0.01%	302
2024 Q1	$385K	Buy	+38,866	New	+$290K	0.02%	231
2023 Q4	–	Sell	-21,535	Closed	-$114K	–	310
2023 Q3	$114K	Sell	21,535 -5,342	-20%	-$45.4K	0.01%	278
2023 Q2	$256K	Buy	26,877 +9,578	+55%	+$106K	0.02%	238
2023 Q1	$190K	Buy	17,299 +1,419	+9%	+$20.5K	0.01%	306
2022 Q4	$235K	Buy	15,880 +3,933	+33%	+$68.7K	0.02%	272
2022 Q3	$228K	Buy	+11,947	New	+$271K	0.02%	279